tirzepatide weight loss clinical trial results once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo- controlled, phase 3 Can Tirzepatide Help You Lose

Choosing the Right Injection Site Best Areas for Injection : Common areas for subcutaneous injections include the fatty tissue of the belly or thigh

These actions help regulate blood sugar and support weight management

Wrong length

A gradual taper over 48 weeks, paired with lifestyle reinforcement, produces far better long-term outcomes and prevents the psychological shock of sudden appetite surge

High-purity research-grade peptide Accurately measured 5mg vial Lyophilised for long-term stability Third-party tested for purity and potency Fast dispatch with reliable packaging Designed for Researchers, By Researchers Cagrilintide 5mg suits a wide range of metabolic and neuroendocrine research applications

Acknowledgements This work was supported by the Research Fund of Ghent University, Belgium, grant BOF08/GOA/004 and BOF14/GOA/010 and Fonds Wetenschappelijk Onderzoek Vlaanderen (grant FWO14/PDO/067)